Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dictyostelium | 16 | 2017 | 116 | 1.960 |
Why?
|
| Computational Biology | 12 | 2016 | 862 | 1.790 |
Why?
|
| Gene Expression Profiling | 16 | 2017 | 1801 | 1.530 |
Why?
|
| User-Computer Interface | 7 | 2017 | 164 | 1.460 |
Why?
|
| Software | 10 | 2014 | 733 | 1.170 |
Why?
|
| Artificial Intelligence | 6 | 2013 | 369 | 0.780 |
Why?
|
| Database Management Systems | 4 | 2013 | 26 | 0.680 |
Why?
|
| Algorithms | 11 | 2016 | 1680 | 0.630 |
Why?
|
| Databases, Genetic | 4 | 2014 | 504 | 0.600 |
Why?
|
| Computer Graphics | 4 | 2014 | 39 | 0.560 |
Why?
|
| Models, Genetic | 6 | 2014 | 749 | 0.520 |
Why?
|
| Data Compression | 1 | 2016 | 11 | 0.480 |
Why?
|
| Internet | 5 | 2017 | 420 | 0.470 |
Why?
|
| Semantics | 1 | 2016 | 47 | 0.470 |
Why?
|
| Sequence Analysis, RNA | 4 | 2017 | 407 | 0.440 |
Why?
|
| Disease | 1 | 2016 | 121 | 0.440 |
Why?
|
| Drug Interactions | 1 | 2016 | 237 | 0.440 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2010 | 992 | 0.440 |
Why?
|
| Databases, Factual | 3 | 2013 | 1240 | 0.430 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 2833 | 0.400 |
Why?
|
| Models, Statistical | 2 | 2014 | 483 | 0.390 |
Why?
|
| Multigene Family | 3 | 2017 | 290 | 0.380 |
Why?
|
| Information Storage and Retrieval | 3 | 2007 | 65 | 0.370 |
Why?
|
| Genomics | 6 | 2010 | 1621 | 0.360 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 226 | 0.350 |
Why?
|
| Femoral Neck Fractures | 1 | 2010 | 9 | 0.330 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 157 | 0.320 |
Why?
|
| Hip Joint | 1 | 2010 | 48 | 0.320 |
Why?
|
| Cell Differentiation | 4 | 2013 | 1928 | 0.320 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2010 | 117 | 0.270 |
Why?
|
| Genome-Wide Association Study | 3 | 2014 | 1833 | 0.270 |
Why?
|
| Cluster Analysis | 3 | 2017 | 414 | 0.260 |
Why?
|
| Saccharomyces cerevisiae | 4 | 2014 | 399 | 0.260 |
Why?
|
| Models, Biological | 2 | 2016 | 1371 | 0.260 |
Why?
|
| Protozoan Proteins | 4 | 2013 | 128 | 0.260 |
Why?
|
| Databases, Protein | 1 | 2007 | 63 | 0.260 |
Why?
|
| Biomedical Engineering | 1 | 2007 | 21 | 0.260 |
Why?
|
| Data Mining | 3 | 2013 | 68 | 0.260 |
Why?
|
| Clinical Medicine | 1 | 2006 | 20 | 0.250 |
Why?
|
| Chromosome Mapping | 2 | 2011 | 1046 | 0.250 |
Why?
|
| Statistics as Topic | 1 | 2006 | 242 | 0.240 |
Why?
|
| Guidelines as Topic | 1 | 2006 | 198 | 0.230 |
Why?
|
| Proteome | 1 | 2007 | 285 | 0.220 |
Why?
|
| Gene Expression Regulation | 2 | 2003 | 2323 | 0.220 |
Why?
|
| Genes | 1 | 2005 | 308 | 0.210 |
Why?
|
| Programming Languages | 1 | 2004 | 17 | 0.210 |
Why?
|
| Computer Simulation | 4 | 2014 | 674 | 0.210 |
Why?
|
| Gene Regulatory Networks | 4 | 2017 | 373 | 0.210 |
Why?
|
| Precision Medicine | 2 | 2018 | 388 | 0.200 |
Why?
|
| Expert Systems | 1 | 2003 | 12 | 0.190 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 680 | 0.190 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2550 | 0.190 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2012 | 950 | 0.180 |
Why?
|
| Gene Expression | 3 | 2011 | 1481 | 0.180 |
Why?
|
| Oogenesis | 2 | 2012 | 50 | 0.170 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2017 | 889 | 0.170 |
Why?
|
| DNA Mutational Analysis | 1 | 2003 | 775 | 0.170 |
Why?
|
| Oocytes | 2 | 2012 | 283 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2011 | 4686 | 0.150 |
Why?
|
| Transcriptome | 2 | 2017 | 1103 | 0.150 |
Why?
|
| Biomarkers, Tumor | 1 | 2007 | 1586 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 1692 | 0.140 |
Why?
|
| Pyrophosphatases | 1 | 2017 | 18 | 0.130 |
Why?
|
| Biomedical Research | 3 | 2008 | 561 | 0.130 |
Why?
|
| DNA, Complementary | 3 | 2013 | 422 | 0.130 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 223 | 0.120 |
Why?
|
| Pattern Recognition, Automated | 2 | 2008 | 40 | 0.120 |
Why?
|
| Bayes Theorem | 2 | 2016 | 311 | 0.120 |
Why?
|
| Gene Ontology | 1 | 2016 | 50 | 0.120 |
Why?
|
| Databases, Pharmaceutical | 1 | 2016 | 6 | 0.120 |
Why?
|
| Classification | 1 | 2016 | 18 | 0.120 |
Why?
|
| Systems Integration | 1 | 2016 | 24 | 0.120 |
Why?
|
| Likelihood Functions | 1 | 2016 | 116 | 0.120 |
Why?
|
| Mutation | 5 | 2013 | 6099 | 0.120 |
Why?
|
| Neoplasms | 2 | 2008 | 3016 | 0.110 |
Why?
|
| Drug Therapy | 1 | 2016 | 85 | 0.110 |
Why?
|
| Probability | 1 | 2016 | 306 | 0.110 |
Why?
|
| Spores, Protozoan | 2 | 2013 | 18 | 0.110 |
Why?
|
| Genome, Protozoan | 2 | 2013 | 25 | 0.110 |
Why?
|
| Epistasis, Genetic | 2 | 2005 | 96 | 0.110 |
Why?
|
| DNA Primers | 2 | 2013 | 599 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2011 | 157 | 0.110 |
Why?
|
| DNA, Fungal | 1 | 2014 | 75 | 0.100 |
Why?
|
| ROC Curve | 1 | 2016 | 613 | 0.100 |
Why?
|
| Animals | 12 | 2012 | 33912 | 0.100 |
Why?
|
| Base Sequence | 3 | 2013 | 2730 | 0.100 |
Why?
|
| Microsatellite Repeats | 1 | 2014 | 204 | 0.100 |
Why?
|
| Wine | 1 | 2013 | 15 | 0.100 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 189 | 0.100 |
Why?
|
| Molecular Sequence Data | 3 | 2013 | 3464 | 0.100 |
Why?
|
| Gram-Positive Bacteria | 1 | 2013 | 44 | 0.100 |
Why?
|
| RNA, Protozoan | 1 | 2013 | 10 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 1 | 2013 | 76 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2013 | 194 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 146 | 0.090 |
Why?
|
| Gene Library | 1 | 2013 | 212 | 0.090 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2012 | 38 | 0.090 |
Why?
|
| Biological Evolution | 2 | 2010 | 222 | 0.090 |
Why?
|
| Machine Learning | 1 | 2016 | 387 | 0.090 |
Why?
|
| Humans | 14 | 2018 | 131163 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2011 | 94 | 0.080 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2010 | 22 | 0.080 |
Why?
|
| Nucleotides | 1 | 2010 | 88 | 0.080 |
Why?
|
| False Positive Reactions | 1 | 2010 | 143 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 1447 | 0.070 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 279 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2010 | 277 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 1363 | 0.070 |
Why?
|
| Genome | 1 | 2011 | 451 | 0.070 |
Why?
|
| Systems Biology | 1 | 2008 | 60 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2010 | 307 | 0.070 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2008 | 19 | 0.070 |
Why?
|
| RNA | 1 | 2011 | 517 | 0.070 |
Why?
|
| Crush Syndrome | 1 | 2007 | 4 | 0.060 |
Why?
|
| Rescue Work | 1 | 2007 | 10 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2014 | 1559 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 533 | 0.060 |
Why?
|
| Social Behavior | 1 | 2009 | 214 | 0.060 |
Why?
|
| Biometry | 1 | 2007 | 101 | 0.060 |
Why?
|
| Stem Cells | 1 | 2011 | 702 | 0.060 |
Why?
|
| Knowledge Bases | 1 | 2006 | 39 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 776 | 0.060 |
Why?
|
| Triage | 1 | 2007 | 144 | 0.060 |
Why?
|
| Disasters | 1 | 2007 | 101 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 668 | 0.060 |
Why?
|
| Rats | 1 | 2011 | 3370 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 981 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2011 | 889 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2007 | 1378 | 0.050 |
Why?
|
| Knowledge | 1 | 2003 | 47 | 0.050 |
Why?
|
| Phenotype | 4 | 2014 | 4497 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 254 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2003 | 238 | 0.050 |
Why?
|
| Larva | 1 | 2003 | 243 | 0.050 |
Why?
|
| Research Design | 1 | 2006 | 716 | 0.040 |
Why?
|
| Research | 1 | 2003 | 264 | 0.040 |
Why?
|
| Genes, Protozoan | 2 | 2013 | 23 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1590 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2003 | 251 | 0.040 |
Why?
|
| Ultraviolet Rays | 2 | 2011 | 192 | 0.040 |
Why?
|
| Mice | 3 | 2012 | 18301 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 6797 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2006 | 1077 | 0.040 |
Why?
|
| DNA | 1 | 2003 | 1399 | 0.030 |
Why?
|
| A549 Cells | 1 | 2017 | 47 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2007 | 3711 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 209 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2017 | 287 | 0.030 |
Why?
|
| Protein Binding | 2 | 2011 | 1652 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 242 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 491 | 0.030 |
Why?
|
| Phylogeny | 1 | 2017 | 689 | 0.030 |
Why?
|
| United States | 2 | 2008 | 12072 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2015 | 220 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2015 | 185 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 151 | 0.020 |
Why?
|
| Cell Line | 1 | 2017 | 2552 | 0.020 |
Why?
|
| Middle Aged | 2 | 2010 | 28601 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 215 | 0.020 |
Why?
|
| Blastomeres | 1 | 2012 | 6 | 0.020 |
Why?
|
| Aged | 1 | 2010 | 21025 | 0.020 |
Why?
|
| Sarcoglycans | 1 | 2011 | 7 | 0.020 |
Why?
|
| Female | 4 | 2012 | 70963 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 254 | 0.020 |
Why?
|
| Muscle Development | 1 | 2011 | 72 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 222 | 0.020 |
Why?
|
| Uridine | 1 | 2010 | 31 | 0.020 |
Why?
|
| RNA Precursors | 1 | 2010 | 42 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 449 | 0.020 |
Why?
|
| Databases, Bibliographic | 1 | 2010 | 19 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 2026 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 3748 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2011 | 235 | 0.020 |
Why?
|
| Adult | 1 | 2010 | 31282 | 0.020 |
Why?
|
| Alleles | 1 | 2014 | 1673 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 470 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 645 | 0.020 |
Why?
|
| Natural Language Processing | 1 | 2010 | 76 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1205 | 0.020 |
Why?
|
| Regeneration | 1 | 2011 | 230 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 686 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 2595 | 0.020 |
Why?
|
| Education | 1 | 2008 | 112 | 0.020 |
Why?
|
| Europe | 1 | 2008 | 365 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6459 | 0.020 |
Why?
|
| Pulse | 1 | 2007 | 28 | 0.020 |
Why?
|
| Urine | 1 | 2007 | 89 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 716 | 0.020 |
Why?
|
| Tachycardia | 1 | 2007 | 66 | 0.020 |
Why?
|
| Male | 2 | 2010 | 64957 | 0.020 |
Why?
|
| Japan | 1 | 2007 | 161 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 246 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 26 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 2006 | 167 | 0.010 |
Why?
|
| Retroelements | 1 | 2006 | 41 | 0.010 |
Why?
|
| Hyperkalemia | 1 | 2007 | 68 | 0.010 |
Why?
|
| Chromosomes | 1 | 2006 | 120 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2007 | 928 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 1207 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2010 | 499 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2005 | 113 | 0.010 |
Why?
|
| CpG Islands | 1 | 2006 | 337 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 6196 | 0.010 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2006 | 156 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 1797 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 2304 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 2406 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 3385 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2007 | 5063 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 4886 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2007 | 17753 | 0.000 |
Why?
|